This week ICER marks the 5-year anniversary of ICER Analytics™, our cloud-based platform that has revolutionized the ability of users to develop formularies, negotiate drug prices, and explore new ways to apply ICER’s evidence. Learn more at analytics.icer.org.

Miss ICER's webinar this week on #GLP-1 #obesity medications? Listen to the recording now: www.youtube.com/watch?featur...

On June 9th at 10 AM CT, ICER's President and CEO Sarah K. Emond, MPP will be part of a live recording for the "Prescription for Better Access" podcast on the future of US drug pricing and patient access. The discussion will take place at the ACCESS US'25 forum.

Register now: www.theaccessforum.org

ICER's President and CEO Sarah K. Emond, MPP will be joining a panel at the UCSF Rosenman Symposium to discuss how to can make groundbreaking cancer therapies accessible while keeping our healthcare system sustainable on May 20th.

Register here: lnkd.in/dxNsSrXF

ICER will be attending #ISPORannual next month! To see the full list of ICER presenters, click here: icer.org/news-insight...

TOMORROW -- On April 22nd at noon ET, ICER will host a public webinar to discuss our recent white paper on policy and market solutions to ensure equitable access to #GLP-1 #obesity medications.

Register here: us02web.zoom.us/webinar/regi...

On May 15th -- ICER's President and CEO, Sarah Emond, will be a speaker at America's Physician Groups Spring Conference. She'll be part of a panel on "Top Pharmaceutical Challenges For Value-Based Care Providers."#APGSC25

Learn more: lnkd.in/gBQhd37C

On March 19th, ICER's Vice President of Research Foluso Agboola will be discussing ICER's Clinical Trial Diversity Rating tool at the Patients as Partners in Clinical Research Conference.

Register here: reg.theconferenceforum.org/event/patien...

#PatientsasPartners2025 #heor #hta

ICER's President and CEO Sarah Emond spoke with Ben Rymzo at the Oliver Wyman Life Sciences Symposium in Philadelphia this week.

Many thanks to Oliver Wyman for inviting ICER and hosting a discussion on biopharma innovation and drug pricing! #OWHIC #hta #heor #drugpricing

ICER's President and CEO Sarah Emond spoke with Ben Rymzo at the Oliver Wyman Life Sciences Symposium in Philadelphia this week.

Many thanks to Oliver Wyman for inviting ICER and hosting a discussion on biopharma innovation and drug pricing!

#OWHIC #hta #heor #drugpricing #valuebasedpricing

On Feb 5th, ICER's Dan Ollendorf will be speaking at the International Conference on Drug Pricing and Affordability. During a panel, Dr. Ollendorf will discuss how HTA can shape drug pricing and coverage decisions.

Register here for the webinar: shorturl.at/ujCy2
#HTA #HEOR @dano-hta.bsky.social

ICER's President and CEO Sarah Emond will be attending the Oliver Wyman Life Sciences Symposium in Philadelphia on February 10-11. She'll lead a discussion on “Valuing Biopharma Innovation: Navigating The Drug Pricing Debate.”

Learn more here: web.cvent.com/event/bc4e44...

#OWHIC #HTA #HEOR